文献速递心境障碍

单分子DNA分析揭示双相障碍脑线粒体病理

Single-molecule DNA analysis implicates brain mitochondria pathology in bipolar disorder.
PubMed 文献 · Mol Psychiatry · 2025-05-29

该研究对54例双相障碍患者、54例对照和55例精神分裂症患者的163份脑DNA样本进行双链分子条形码测序,以单分子分辨率分析线粒体异质性变异。发现双相障碍中富集等位分数超过1%的超罕见异质性变异,包括m.3243A>G、功能丧失变异和rRNA变异,提示部分双相障碍患者可按超罕见线粒体变异进行分层。

要点

  • 双相障碍脑组织富集等位分数>1%的超罕见线粒体异质性变异。
  • 潜在致病变异(m.3243A>G、功能丧失、rRNA变异)在双相障碍中尤其富集。
  • 未发现双相障碍低水平异质性变异在每碱基突变频率和异质性分数上普遍升高。

核心结论

  • 双相障碍与脑线粒体超罕见异质性变异富集相关,部分患者可据此分层。

研究设计与样本

  • 研究分析163份脑DNA样本,来自54例双相障碍患者、54例对照和55例精神分裂症患者。
  • 采用双链分子条形码测序实现单分子分辨率检测线粒体异质性变异。

主要发现

  • 双相障碍中富集等位分数超过1%的超罕见异质性变异。
  • 潜在致病变异包括m.3243A>G、功能丧失变异和rRNA变异在双相障碍中尤其富集。
  • 单分子分析未发现双相障碍低水平异质性变异在每碱基突变频率和异质性分数上普遍增加。

关键数值与推荐

  • 超罕见异质性变异定义为等位分数超过1%。

临床怎么用

  • 部分双相障碍患者可依据超罕见线粒体变异的存在进行基因组分层。
  • 该发现为未来基于线粒体变异基因组分层的靶向治疗策略研究提供基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bipolar disorder (BD), characterized by recurrent manic and depressive episodes, is a global medical challenge. Based on its high heritability, various genomic studies have elucidated the genetic architecture of BD. Nonetheless, the specific genomic mechanisms underpinning BD pathogenesis remain elusive. Among under-investigated genomic factors, mitochondrial variants-particularly brain heteroplasmic variants-are of particular interest, given the critical role of mitochondria in neural function and the frequent psychiatric symptoms observed in mitochondrial diseases. In this study, we analyzed 163 brain DNA samples from 54 BD patients, 54 controls, and 55 schizophrenia patients to investigate the association between BD and mitochondrial heteroplasmic variants. Duplex molecular barcoding sequencing was employed for single-molecule resolution. We found an enrichment of ultra-rare heteroplasmic variants with allele fractions exceeding 1% in BD. Among them, potentially pathogenic variants, including m.3243A>G, loss-of-function variants, and rRNA variants, were particularly enriched in BD. In contrast, single-molecule analysis did not reveal a general trend of increases in low-level heteroplasmic variants in BD, in terms of per-base mutation frequency and heteroplasmic fractions. Thus, a subset of BD patients may be stratified according to the presence of ultra-rare mitochondrial variants. Our findings provide a foundation for future research into targeted therapeutic strategies for BD, grounded in genomic stratification by mitochondrial variants.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ohtani H, Ichikawa R, Mori K, et al. Single-molecule DNA analysis implicates brain mitochondria pathology in bipolar disorder. Mol Psychiatry. 2025. PMID: 40442452. doi:10.1038/s41380-025-03071-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。